Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |